Lacticin 3147 - Biosynthesis, Molecular Analysis, Immunity, Bioengineering and Applications

Current Protein and Peptide Science

Volumn 13, Issue 3, 2012, Pages 193-204

  Suda, Srinivas ^a   Cotter, Paul D ^b,c   Hill, Colin ^a,c   Ross, R Paul ^b,c  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b TEAGASC FOOD RESEARCH CENTRE   (Ireland)

^c UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Antimicrobial peptides; Bacteriocins; Bioengineering; Lacticin 3147; Lantibiotic applications; Lantibiotics; Mutagenesis

Indexed keywords

BACTERIAL PROTEIN; CYTOLYSIN; KEFIR; LACTICIN 3147; LANTIBIOTIC; STAPHYLOCOCCUS PROTEIN A; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; BACILLUS LICHENIFORMIS; BACTERIAL FLORA; BACTERIAL GENE; BACTERIAL IMMUNITY; BACTERIAL MEMBRANE; BIOENGINEERING; BOVINE MASTITIS; CONCENTRATION RESPONSE; CYTOLYSIS; DRUG ACTIVITY; DRUG EFFICACY; DRUG MECHANISM; DRUG SCREENING; DRUG SYNTHESIS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; FERMENTATION; FOOD INDUSTRY; FOOD PRESERVATION; FOOD SPOILAGE; GENETIC ENGINEERING AND GENE TECHNOLOGY; IMMUNITY; LACTIC ACID BACTERIUM; LACTOBACILLUS; LACTOBACILLUS PLANTARUM; LACTOCOCCUS LACTIS; LEUCONOSTOC; LISTERIA MONOCYTOGENES; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MUTAGENESIS; NONHUMAN; PH; PROPIONIBACTERIUM ACNES; REVIEW; STREPTOCOCCUS MUTANS; STRUCTURE ACTIVITY RELATION; VANCOMYCIN RESISTANT ENTEROCOCCUS; YEAST;

AMINO ACID SEQUENCE; ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIOCIN PLASMIDS; BACTERIOCINS; DRUG RESISTANCE, NEOPLASM; FOOD MICROBIOLOGY; FOOD PRESERVATION; HUMANS; MICROBIAL VIABILITY; MOLECULAR SEQUENCE DATA; PROTEIN ENGINEERING; VETERINARY MEDICINE;

EID: 84862578924     PISSN: 13892037     EISSN: 18755550     Source Type: Journal    
DOI: 10.2174/138920312800785021     Document Type: Review

References (108)

1. Jack, R.W.; Tagg, J.R.; Ray, B. Bacteriocins of gram-positive bacteria. Microbiol. Rev., 1995, 59 (2), 171-200.
2. Tagg, J.R.; Dajani, A.S.; Wannamaker, L.W. Bacteriocins of Gram-positive bacteria. Bacteriol. Rev., 1976, 40 (3), 722-756.
3. Cotter, P.D.; Hill, C.; Ross, R.P. Bacteriocins: developing innate immunity for food. Nat. Rev. Microbiol., 2005, 3 (10), 777-788.
4. Gross, E.; Morell, J.L. The structure of nisin. J. Am. Chem. Soc., 1971, 93 (18), 4634-4635.
5. Hurst, A. Nisin Adv. Appl. Microbiol., 1981, In. Perlman, D. and Laskin, A.I. eds. Vol.27 (Academic Press, New York), 85-123.
6. Suda, S.; Westerbeek, A.; O'Connor, P.M.; Ross, R.P.; Hill, C.; Cotter, P.D. Effect of bioengineering lacticin 3147 lanthionine bridges on specific activity and resistance to heat and proteases. Chem. Biol., 2010, 17 (10), 1151-1160.
7. De Vuyst, L. Nisin, A lantibiotic produced by Lactococcus lactis subsp. lactis: Properties, biosynthesis, fermentation and applications. 1985, (In: L De Vuyst, EJ Vandamme, eds. Bacteriocins of Lactic Acid Bacteria: Microbiology, Genetics and Applications), 151-221.
8. Bierbaum, G.; Szekat, C.; Josten, M.; Heidrich, C.; Kempter, C.; Jung, G.; Sahl, H.G. Engineering of a novel thioether bridge and role of modified residues in the lantibiotic Pep5. Appl. Environ. Microbiol., 1996, 62 (2), 385-392.
9. Rink, R.; Arkema-Meter, A.; Baudoin, I.; Post, E.; Kuipers, A.; Nelemans, S.A.; Akanbi, M.H.; Moll, G.N. To protect peptide pharmaceuticals against peptidases. J. Pharmacol. Toxicol. Methods., 2010, 61 (2), 210-218.
10. Rew, Y.; Malkmus, S.; Svensson, C.; Yaksh, T.L.; Chung, N.N.; Schiller, P.W.; Cassel, J.A.; DeHaven, R.N.; Taulane, J.P.; Goodman, M. Synthesis and biological activities of cyclic lanthionine enkephalin analogues: delta-opioid receptor selective ligands. J. Med. Chem., 2002, 45 (17), 3746-3754.
11. Kluskens, L.D.; Nelemans, S.A.; Rink, R.; de Vries, L.; Meter- Arkema, A.; Wang, Y.; Walther, T.; Kuipers, A.; Moll, G.N.; Haas, M. Angiotensin-(1-7) with thioether bridge: an angiotensinconverting enzyme-resistant, potent angiotensin-(1-7) analog. J. Pharmacol. Exp. Ther., 2009, 328 (3), 849-854.
12. Sahl, H.G.; Jack, R. W.; Bierbaum, G. Biosynthesis and biological activities of lantibiotics with unique post-translational modifications. Eur. J. Biochem., 1995, 230 (3), 827-853.
13. Cebrian, R.; Maqueda, M.; Neira, J.L.; Valdivia, E.; Martinez- Bueno, M.; Montalban-Lopez, M. Insights into the functionality of the putative residues involved in enterocin AS-48 maturation. Appl. Environ. Microbiol., 2010, 76 (21), 7268-7276.
14. Liu, H.; Pattabiraman, V.R.; Vederas, J.C. Synthesis and biological activity of oxa-lacticin A2, a lantibiotic analogue with sulfur replaced by oxygen. Org. Lett., 2009, 11 (24), 5574-5577.
15. Wilson-Stanford, S.; Kalli, A.; Hakansson, K.; Kastrantas, J.; Orugunty, R.S.; Smith, L. Oxidation of lanthionines renders the lantibiotic nisin inactive. Appl. Environ. Microbiol., 2009, 75 (5), 1381-1387.
16. Rogers, L.A. The Inhibiting Effect of Streptococcus Lactis on Lactobacillus Bulgaricus. J. Bacteriol., 1928, 16 (5), 321-325.
17. Delves Broughton J. Nisin and its use as a food preservative. Food Tech., 1990, 44, 100-117.
18. Piper, C.; Cotter, P.D.; Ross, R.P.; Hill, C. Discovery of medically significant lantibiotics. Curr. Drug Discov. Technol., 2009, 6 (1), 1-18.
19. Field, D.; Hill, C.; Cotter, P.D.; Ross, R.P. The dawning of a 'Golden era' in lantibiotic bioengineering. Mol. Microbiol., 2010, 78 (5), 1077-1087.
20. Ryan, M.P.; Rea, M.C.; Hill, C.; Ross, R.P. An application incheddar cheese manufacture for a strain of Lactococcus lactis producing a novel broad-spectrum bacteriocin, lacticin 3147. Appl. Environ. Microbiol., 1996, 62 (2), 612-619.
21. Galvin, M.; Hill, C.; Ross, R.P. Lacticin 3147 displays activity in buffer against Gram-positive bacterial pathogens which appear insensitive in standard plate assays. Lett. Appl. Microbiol., 1999, 28 (5), 355-358.
22. Rea, M.C.; Clayton, E.; O'Connor, P.M.; Shanahan, F.; Kiely, B.; Ross, R.P.; Hill, C. Antimicrobial activity of lacticin 3,147 against clinical Clostridium difficile strains. J. Med. Microbiol., 2007, 56 (Pt 7), 940-946.
23. Field, D.; Connor, P.M.; Cotter, P.D.; Hill, C.; Ross, R.P. The generation of nisin variants with enhanced activity against specific gram-positive pathogens. Mol. Microbiol., 2008, 69 (1), 218-230.
24. Rea, M.C.; Dobson, A.; O'Sullivan, O.; Crispie, F.; Fouhy, F.; Cotter, P.D.; Shanahan, F.; Kiely, B.; Hill, C.; Ross, R.P. Microbes and Health Sackler Colloquium: Effect of broad- and narrow spectrum antimicrobials on Clostridium difficile and microbial diversity in a model of the distal colon. Proc. Natl. Acad. Sci. USA, 2010.
25. Piper, C.; Draper, L.A.; Cotter, P.D.; Ross, R.P.; Hill, C. A comparison of the activities of lacticin 3147 and nisin against drugresistant Staphylococcus aureus and Enterococcus species. J. Antimicrob. Chemother., 2009.
26. Carroll, J.; Draper, L.A.; O'Connor, P.M.; Coffey, A.; Hill, C.; Ross, R.P.; Cotter, P.D.; O'Mahony, J. Comparison of the activities of the lantibiotics nisin and lacticin 3147 against clinically significant mycobacteria. Int. J. Antimicrob. Agents, 2010.
27. Rea, M.C.; Lennartsson, T.; Dillon, P.; Drinan, F.D.; Reville, W.J.; Heapes, M.; Coga, T.M. Irish kefir-like grains: their structure, microbial composition and fermentation kinetics. J. Appl. Bacteriol., 1996, 81, 83-94.
28. Casla, D.; Requena, T.; Gomez, R. Antimicrobial activity of lactic acid bacteria isolated from goat's milk and artisanal cheeses: characteristics of a bacteriocin produced by Lactobacillus curvatus IFPL 105. J. Appl. Bacteriol., 1996, 81 (1), 35-41.
29. Martinez-Cuesta, M.C.; Buist, G.; Kok, J.; Hauge, H.H.; Nissen- Meyer, J.; Pelaez, C.; Requena, T. Biological and molecular characterization of a two-peptide lantibiotic produced by Lactococcus lactis IFPL105. J. Appl. Microbiol., 2000, 89 (2), 249-260.
30. Settanni, L.; Massitti, O.; Van Sinderen, D.; Corsetti, A. In situ activity of a bacteriocin-producing Lactococcus lactis strain. Influence on the interactions between lactic acid bacteria during sourdough fermentation. J. Appl. Microbiol., 2005, 99 (3), 670-681.
31. Kilpper Balz, R.F.G.; Schleifer, K.H. Nucleic acid hybridisation of group N and group D streptococci. Curr. Microbiol., 1982, 7, 245-250.
32. McAuliffe, O.; Hill, C.; Ross, R.P. Identification and over expression of ltnl, a novel gene which confers immunity to the two-component lantibiotic lacticin 3147. Microbiology, 2000, 146 (Pt 1), 129-138.
33. Cotter, P.D.; Draper, L.A.; Lawton, E.M.; McAuliffe, O.; Hill, C.; Ross, R.P. Overproduction of wild-type and bioengineered derivatives of the lantibiotic lacticin 3147. Appl. Environ. Microbiol., 2006, 72 (6), 4492-4496.
34. Dougherty, B.A.; Hill, C.; Weidman, J.F.; Richardson, D.R.; Venter, J.C.; Ross, R.P. Sequence and analysis of the 60 kb conjugative, bacteriocin-producing plasmid pMRC01 fromLactococcus lactis DPC3147. Mol. Microbiol., 1998, 29 (4), 1029-1038.
35. McAuliffe, O.; Hill, C.; Ross, R.P. Each peptide of the two component lantibiotic lacticin 3147 requires a separate modification enzyme for activity. Microbiology, 2000, 146 (Pt 9), 2147-2154.
36. McAuliffe, O.; O'Keeffe, T.; Hill, C.; Ross, R.P. Regulation of immunity to the two-component lantibiotic, lacticin 3147, by the transcriptional repressor LtnR. Mol. Microbiol., 2001, 39 (4), 982-993.
37. Cotter, P.D.; O'Connor, P.M.; Draper, L.A.; Lawton, E.M.; Deegan, L.H.; Hill, C.; Ross, R.P. Posttranslational conversion of L-serines to D-alanines is vital for optimal production and activity of the lantibiotic lacticin 3147. Proc. Natl. Acad. Sci. USA, 2005, 102 (51), 18584-18589.
38. Yamaguchi, T.; Hayashi, T.; Takami, H.; Ohnishi, M.; Murata, T.; Nakayama, K.; Asakawa, K.; Ohara, M.; Komatsuzawa, H.; Sugai, M. Complete nucleotide sequence of a Staphylococcus aureus exfoliative toxin B plasmid and identification of a novel ADPribosyltransferase, EDIN-C. Infect. Immun., 2001, 69 (12), 7760-7771.
39. Navaratna, M.A.; Sahl, H.G.; Tagg, J.R. Two-component anti- Staphylococcus aureus lantibiotic activity produced by Staphylococcus aureus C55. Appl. Environ. Microbiol., 1998, 64 (12), 4803-4808.
40. Lawton, E.M.; Cotter, P.D.; Hill, C.; Ross, R.P. Identification of a novel two-peptide lantibiotic, haloduracin, produced by the alkaliphile Bacillus halodurans C-125. FEMS Microbiol. Lett., 2007, 267 (1), 64-71.
41. McClerren, A.L.; Cooper, L.E.; Quan, C.; Thomas, P.M.; Kelleher, N.L.; van der Donk, W.A. Discovery and in vitro biosynthesis of haloduracin, a two-component lantibiotic. Proc. Natl. Acad. Sci. USA, 2006, 103 (46), 17243-17248.
42. Holo, H.; Jeknic, Z.; Daeschel, M.; Stevanovic, S.; Nes, I.F. Plantaricin W from Lactobacillus plantarum belongs to a new family of two-peptide lantibiotics. Microbiology, 2001, 147 (Pt 3), 643-651.
43. Yonezawa, H.; Kuramitsu, H.K. Genetic analysis of a unique bacteriocin, Smb, produced by Streptococcus mutans GS5. Antimicrob. Agents Chemother., 2005, 49 (2), 541-548.
44. Hyink, O.; Balakrishnan, M.; Tagg, J.R. Streptococcus rattus strain BHT produces both a class I two-component lantibiotic and a class II bacteriocin. FEMS Microbiol. Lett., 2005, 252 (2), 235-241.
45. Begley, M.; Cotter, P.D.; Hill, C.; Ross, R.P. Identification of a novel two-peptide lantibiotic, lichenicidin, following rational genome mining for LanM proteins. Appl. Environ. Microbiol., 2009, 75 (17), 5451-5460.
46. Dischinger, J.; Josten, M.; Szekat, C.; Sahl, H.G.; Bierbaum, G. Production of the novel two-peptide lantibiotic lichenicidin by Bacillus licheniformis DSM 13. PLoS One, 2009, 4 (8), e6788.
47. Booth, M.C.; Bogie, C.P.; Sahl, H.G.; Siezen, R.J.; Hatter, K.L.; Gilmore, M.S. Structural analysis and proteolytic activation of Enterococcus faecalis cytolysin, a novel lantibiotic. Mol. Microbiol., 1996, 21 (6), 1175-1184.
48. Martin, N.I.; Sprules, T.; Carpenter, M.R.; Cotter, P.D.; Hill, C.; Ross, R.P.; Vederas, J.C. Structural characterization of lacticin 3147, a two-peptide lantibiotic with synergistic activity. Biochemistry, 2004, 43 (11), 3049-3056.
49. Skaugen, M.; Nissen-Meyer, J.; Jung, G.; Stevanovic, S.; Sletten, K.; Inger, C.; Abildgaard, M.; Nes, I.F. In vivo conversion of Lserine to D-alanine in a ribosomally synthesized polypeptide. J. Biol. Chem., 1994, 269 (44), 27183-27185.
50. Ryan, M.P.; Jack, R.W.; Josten, M.; Sahl, H.G.; Jung, G.; Ross, R.P.; Hill, C. Extensive post-translational modification, including serine to D-alanine conversion, in the two-component lantibiotic, lacticin 3147. J. Biol. Chem., 1999, 274 (53), 37544-37550.
51. McAuliffe, O.; Ryan, M.P.; Ross, R.P.; Hill, C.; Breeuwer, P.; Abee, T. Lacticin 3147, a broad-spectrum bacteriocin which selectively dissipates the membrane potential. Appl. Environ. Microbiol., 1998, 64 (2), 439-445.
52. Wiedemann, I.; Bottiger, T.; Bonelli, R.R.; Wiese, A.; Hagge, S.O.; Gutsmann, T.; Seydel, U.; Deegan, L.; Hill, C.; Ross, P.; Sahl, H.G. The mode of action of the lantibiotic lacticin 3147--a complex mechanism involving specific interaction of two peptides and the cell wall precursor lipid II. Mol. Microbiol., 2006, 61 (2), 285-296.
53. Ryan, M.P.; Flynn, J.; Hill, C.; Ross, R.P.; Meaney, W.J. The natural food grade inhibitor, lacticin 3147, reduced the incidence of mastitis after experimental challenge with Streptococcus dysgalactiae in nonlactating dairy cows. J. Dairy Sci., 1999, 82 (12), 2625-2631.
54. Morgan, S.M.; O'Connor, P.M.; Cotter, P.D.; Ross, R.P.; Hill, C. Sequential actions of the two component peptides of the lantibiotic lacticin 3147 explain its antimicrobial activity at nanomolar concentrations. Antimicrob. Agents Chemother., 2005, 49 (7), 2606-2611.
55. Oman, T.J.; van der Donk, W.A. Insights into the mode of action of the two-peptide lantibiotic haloduracin. ACS Chem. Biol., 2009, 4 (10), 865-874.
56. Ryan, M.P.; McAuliffe, O.; Ross, R.P.; Hill, C. Heterogonous expression of lacticin 3147 in Enterococcus faecalis: comparison of biological activity with cytolysin. Lett. Appl. Microbiol., 2001, 32(2), 71-77.
57. Draper, L.A.; Ross, R.P.; Hill, C.; Cotter, P.D. Lantibiotic immunity. Curr. Prot. Pept. Sci., 2008, 9 (1), 39-49.
58. Aso, Y.; Okuda, K.; Nagao, J.; Kanemasa, Y.; Thi Bich Phuong, N.; Koga, H.; Shioya, K.; Sashihara, T.; Nakayama, J.; Sonomoto, K. A novel type of immunity protein, NukH, for the lantibiotic nukacin ISK-1 produced by Staphylococcus warneri ISK-1. Biosci. Biotechnol. Biochem., 2005, 69 (7), 1403-1410.
59. Ross, J.I.; Eady, E.A.; Cove, J.H.; Baumberg, S. Identification of a chromosomally encoded ABC-transport system with which the staphylococcal erythromycin exporter MsrA may interact. Gene 1995, 153 (1), 93-98.
60. Draper, L.A.; Grainger, K.; Deegan, L.H.; Cotter, P.D.; Hill, C.; Ross, R.P. Cross-immunity and immune mimicry as mechanisms of resistance to the lantibiotic lacticin 3147. Mol. Microbiol., 2009, 71 (4), 1043-1054.
61. Guinane, C.M.; Cotter, P.D.; Hill, C.; Ross, R.P. Spontaneous resistance in Lactococcus lactis IL1403 to the lantibiotic lacticin 3147. FEMS Microbiol. Lett., 2006, 260 (1), 77-83.
62. Guinane, C.M.; Cotter, P.D.; Lawton, E.M.; Hill, C.; Ross, R.P. Insert ional mutagenesis to generate lantibiotic resistance in Lactococcus lactis. Appl. Environ. Microbiol., 2007, 73 (14), 4677-4680.
63. Begley, M.; Hill, C.; Ross, R.P. Tolerance of Listeria monocytogenes to cell envelope-acting antimicrobial agents is dependent on SigB. Appl. Environ. Microbiol., 2006, 72 (3), 2231-2234.
64. Pattabiraman, V.R.; McKinnie, S.M.; Vederas, J.C. Solidsupported synthesis and biological evaluation of the lantibiotic peptide bis(desmethyl) lacticin 3147 A2. Angew. Chem. Int. Ed. Engl., 2008, 47 (49), 9472-9475.
65. Pattabiraman, V.R.; Stymiest, J.L.; Derksen, D.J.; Martin, N.I.; Vederas, J.C. Multiple on-resin olefin metathesis to form ringexpanded analogues of the lantibiotic peptide, lacticin 3147 A2. Org. Lett., 2007, 9 (4), 699-702.
66. Cotter, P.D.; Deegan, L.H.; Lawton, E.M.; Draper, L.A.; O'Connor, P.M.; Hill, C.; Ross, R.P. Complete alanine scanning of the twocomponent lantibiotic lacticin 3147: generating a blueprint for rational drug design. Mol. Microbiol., 2006, 62 (3), 735-747.
67. Kuipers, O.P.; Rollema, H.S.; Yap, W.M.; Boot, H.J.; Siezen, R.J.; de Vos, W.M. Engineering dehydrated amino acid residues in the antimicrobial peptide nisin. J. Biol. Chem., 1992, 267 (34), 24340-24346.
68. Liu, W.; Hansen, J.N. Enhancement of the chemical and antimicrobial properties of subtilin by site-directed mutagenesis. J. Biol. Chem., 1992, 267 (35), 25078-25085.
69. Yuan, J.; Zhang, Z.Z.; Chen, X.Z.; Yang, W.; Huan, L.D. Sitedirected mutagenesis of the hinge region of nisinZ and properties of nisinZ mutants. Appl. Microbiol. Biotechnol., 2004, 64 (6), 806-815.
70. Rollema, H.S.; Kuipers, O.P.; Both, P.; de Vos, W.M.; Siezen, R.J. Improvement of solubility and stability of the antimicrobial peptide nisin by protein engineering. Appl. Environ. Microbiol., 1995, 61 (8), 2873-2878.
71. Field, D.; Collins, B.; Cotter, P.D.; Hill, C.; Ross, R.P. A system for the random mutagenesis of the two-peptide lantibiotic lacticin 3147: analysis of mutants producing reduced antibacterial activities. J. Mol. Microbiol. Biotechnol., 2007, 13 (4), 226-234.
72. Deegan, L.H.; Suda, S.; Lawton, E.M.; Draper, L.A.; Hugenholtz, F.; Peschel, A.; Hill, C.; Cotter, P.D.; Ross, R.P. Manipulation of charged residues within the two-peptide lantibiotic lacticin 3147. Microbial. Biotechnol., 2010, 3 (2), 222-234.
73. Suda, S.; Hill, C.; Cotter, P.D.; Ross, R.P. Investigating the importance of charged residues in lantibiotics. Bioengineered Bugs, 2010, 1:5, 345-351.
74. Kuipers, A.; Meijer-Wierenga, J.; Rink, R.; Kluskens, L.D.; Moll G.N. Mechanistic dissection of the enzyme complexes involved in biosynthesis of lacticin 3147 and nisin. Appl. Environ. Microbiol., 2008, 74 (21), 6591-6597.
75. Deegan, L.H.; Cotter, P.D.; Hill, C.; Ross, P. Bacteriocins: Biological tools for bio-preservation and shelf-life extension. Int. Dairy J., 2006, 16 (9), 1058-1071.
76. Hickey, R.M.; Twomey, D.P.; Ross, R.P.; Hill, C. Exploitation of plasmid pMRC01 to direct transfer of mobilizable plasmids into commercial lactococcal starter strains. Appl. Environ. Microbiol., 2001, 67 (6), 2853-2858.
77. Coakley, M.; Fitzgerald, G.; Ross, R.P. Application and evaluation of the phage resistance- and bacteriocin-encoding plasmid pMRC01 for the improvement of dairy starter cultures. Appl. Environ. Microbiol., 1997, 63 (4), 1434-1440.
78. Trotter, M.; McAuliffe, O.E.; Fitzgerald, G.F.; Hill, C.; Ross, R.P.; Coffey, A. Variable bacteriocin production in the commercial starter Lactococcus lactis DPC4275 is linked to the formation of the cointegrate plasmid pMRC02. Appl. Environ. Microbiol., 2004, 70 (1), 34-42.
79. Fallico, V.; McAuliffe, O.; Fitzgerald, G.F.; Hill, C.; Ross, R.P. The presence of pMRC01 promotes greater cell permeability and autolysis in lactococcal starter cultures. Int. J. Food Microbiol., 2009, 133 (3), 217-224.
80. Martinez-Cuesta, M.C.; Requena, T.; Pelaez, C. Use of a bacteriocin-producing transconjugant as starter in acceleration of cheese ripening. Int. J. Food Microbiol., 2001, 70 (1-2), 79-88.
81. Martinez-Cuesta, C.; Requena, T.; Pelaez, C. Effect of bacteriocininduced cell damage on the branched-chain amino acid transamination by Lactococcus lactis. FEMS Microbiol. Lett., 2002, 217 (1), 109-113.
82. Fernandez de Palencia, P.; de la Plaza, M.; Mohedano, M.L.; Martinez-Cuesta, M.C.; Requena, T.; Lopez, P.; Pelaez, C. Enhancement of 2-methylbutanal formation in cheese by using a fluorescently tagged Lacticin 3147 producing Lactococcus lactis strain. Int. J. Food Microbiol., 2004, 93 (3), 335-347.
83. Martinez-Cuesta, M.C.; Requena, T.; Pelaez, C. Cell membrane damage induced by lacticin 3147 enhances aldehyde formation in Lactococcus lactis IFPL730. Int. J. Food Microbiol., 2006, 109 (3), 198-204.
84. McAuliffe, O.; Hill, C.; Ross, R.P. Inhibition of Listeria monocytogenes in cottage cheese manufactured with a lacticin 3147-producing starter culture. J. Appl. Microbiol., 1999, 86 (2), 251-256.
85. Ross, R.P.; Stanton, C.; Hill, C.; Fitzgerald, G.F.; Coffey, A. Novel cultures for cheese improvement. Trends in Food Sci. Technol., 2000, 11 (3), 96-104.
86. O'Sullivan, L.; Coffey, A.; Ross, R.P.; Hill, C. Evaluation of live-culture-producing lacticin 3147 as a treatment for the control of Listeria monocytogenes on the surface of smear-ripened cheese. J. Appl. Microbiol., 2006, 100 (1), 1351-43.
87. Coffey, A.; Ryan, M.; Ross, R.P.; Hill, C.; Arendt, E.; Schwarz, G. Use of a broad-host-range bacteriocin-producing Lactococcus lactis transconjugant as an alternative starter for salami manufacture. Int.J. Food Microbiol., 1998, 43 (3), 231-235.
88. Scannell, A.G.; Schwarz, G.; Hill, C.; Ross, R.P.; Arendt, E.K. Preinoculation enrichment procedure enhances the performance of bacteriocinogenic Lactococcus lactis meat starter culture. Int. J. Food Microbiol., 2001, 64 (1-2), 151-159.
89. Morgan, S. M.; Galvin, M.; Kelly, J.; Ross, R. P.; Hill, C. Development of a lacticin 3147-enriched whey powder with inhibitory activity against foodborne pathogens. J. Food Prot., 1999, 62 (9), 1011-6.
90. Morgan, S.M.; Galvin, M.; Ross, R.P.; Hill, C. Evaluation of a spray-dried lacticin 3147 powder for the control of Listeria monocytogenes and Bacillus cereus in a range of food systems. Lett. Appl. Microbiol., 2001, 33 (5), 387-391.
91. Scannell, A.G.; Hill, C.; Ross, R.P.; Marx, S.; Hartmeier, W.; Arendt, E.K. Continuous production of lacticin 3147 and nisin using cells immobilized in calcium alginate. J. Appl. Microbiol.,2000, 89 (4), 573-579.
92. Huang, J.; Lacroix, C.; Daba, H.; Simard, R.E. Pediocin 5 production and plasmid stability during continuous free and immobilized cell cultures of Pediococcus acidilactici UL5. J. Appl. Bacteriol., 1996, 80 (6), 635-644.
93. Scannell, A.G.; Hill, C.; Ross, R.P.; Marx, S.; Hartmeier, W.; Elke Arendt, K. Development of bioactive food packaging materials using immobilised bacteriocins lacticin 3147 and nisaplin. Int. J. Food Microbiol., 2000, 60 (2-3), 241-249.
94. Morgan, S.M.; Ross, R.P.; Beresford, T.; Hill, C. Combination of hydrostatic pressure and lacticin 3147 causes increased killing of Staphylococcus and Listeria. J. Appl. Microbiol., 2000, 88 (3), 414-420.
95. Scannell, A.G.; Ross, R.P.; Hill, C.; Arendt, E.K. An effective lacticin biopreservative in fresh pork sausage. J. Food Prot., 2000, 63 (3), 370-375.
96. van Schaik, W.; Gahan, C.; Hill, C. Acid-adapted Listeria monocytogenes displays enhanced tolerance against the lantibiotics nisin and lacticin 3147. J. Food Prot., 1999, 62 (5), 536-539.
97. Mota-Meira, M.; LaPointe, G.; Lacroix, C.; Lavoie, M.C. MICs of mutacin B-Ny266, nisin A, vancomycin, and oxacillin against bacterial pathogens. Antimicrob. Agents Chemother., 2000, 44 (1), 24-29.
98. Ghobrial, O.G.; Derendorf, H.; Hillman, J.D. Pharmacodynamic activity of the lantibiotic MU1140. Int. J. Antimicrob. Agents, 2009, 33 (1), 70-74.
99. Severina, E.; Severin, A.; Tomasz, A. Antibacterial efficacy of nisin against multidrug-resistant Gram-positive pathogens. J. Antimicrob. Chemother., 1998, 41 (3), 341-347.
100. Brumfitt, W.; Salton, M.R.; Hamilton-Miller, J.M. Nisin, alone and combined with peptidoglycan-modulating antibiotics: activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci. J. Antimicrob. Chemother., 2002, 50 (5), 731-734.
101. O'Connor, E.B.; O'Riordan, B.; Morgan, S.M.; Whelton, H.; O'Mullane, D.M.; Ross, R.P.; Hill, C. A lacticin 3147 enriched food ingredient reduces Streptococcus mutans isolated from the human oral cavity in saliva. J. Appl. Microbiol., 2006, 100 (6), 1251-1260.
102. Gardiner, G.E.; Rea, M.C.; O'Riordan, B.; O'Connor, P.; Morgan, S.M.; Lawlor, P.G.; Lynch, P.B.; Cronin, M.; Ross, R.P.; Hill, C. Fate of the two-component lantibiotic lacticin 3147 in the gastrointestinal tract. Appl. Environ. Microbiol., 2007, 73 (21), 7103-7109.
103. Silkin, L.; Hamza, S.; Kaufman, S.; Cobb, S.L.; Vederas, J.C. Spermicidal bacteriocins: lacticin 3147 and subtilosin A. Bioorg. Med. Chem. Lett., 2008, 18 (10), 3103-3106.
104. Ryan, M.P.; Meaney, W.J.; Ross, R.P.; Hill, C. Evaluation of lacticin 3147 and a teat seal containing this bacteriocin for inhibition of mastitis pathogens. Appl. Environ. Microbiol., 1998, 64 (6), 2287-2290.
105. Twomey, D.P.; Wheelock, A.I.; Flynn, J.; Meaney, W.J.; Hill, C.; Ross, R.P. Protection against Staphylococcus aureus mastitis in dairy cows using a bismuth-based teat seal containing the bacteriocin, lacticin 3147. J. Dairy Sci., 2000, 83 (9), 1981-1988.
106. Crispie, F.; Twomey, D.; Flynn, J.; Hill, C.; Ross, P.; Meaney, W. The lantibiotic lacticin 3147 produced in a milk-based medium improves the efficacy of a bismuth-based teat seal in cattle deliberately infected with Staphylococcus aureus. J. Dairy Res., 2005, 72 (2), 159-167.
107. Klostermann, K.; Crispie, F.; Flynn, J.; Meaney, W.J.; Paul Ross, R.; Hill, C. Efficacy of a teat dip containing the bacteriocin lacticin3147 to eliminate Gram-positive pathogens associated with bovine mastitis. J. Dairy Res., 2010, 77 (2), 231-238.
108. McClerren, A.L.; Cooper, L.E.; Quan, C.; Thomas, P.M.; Kelleher, N.L.; van der Donk, W.A. Discovery and in vitro biosynthesis of haloduracin, a two-component lantibiotic. Proc. Natl. Acad. Sci. USA, 2006, 103 (46), 17243-17248.